Skip to main content

Table 1 Conporto EDM alerts

From: Medication risk management and health equity in New Zealand general practice: a retrospective cross-sectional study

 

Alert

Description

1

Allopurinol > 200 mg, eGFR < 30

Allopurinol prescribed at a dose of > 200 mg/day to a patient with chronic renal insufficiency (eGFR < 30 mL/min/1.73 m2)a

2

Macrolide & simvastatin

Prescription for an macrolide antibiotic, with a co-prescription for simvastatin

3

Bupropion epilepsy

Bupropion (Zyban) prescribed to a patient with epilepsy

4

Metformin eGFR < 30

Metformin prescribed to a patient with renal insufficiency where the eGFR is < 30 mL/min/1.73 m2

5

MTX no Folic acid

Prescription of methotrexate, without a co-prescription for folic acid

6

NSAID eGFR < 45

Prescription of a NSAIDb, in a patient with chronic renal insufficiency (eGFR < 45 mL/min/1.73 m2)

7

NSAID, Ulcer, no PPI

Prescription of a NSAID, without co-prescription for an proton-pump inhibitor to a patient with a history of peptic ulceration

8

PDEi & Nitrite

Prescription of a phosphodiesterase type-5 inhibitor, with a co-prescription for a nitrate

9

Valproate F epilepsy

Prescription of sodium valproate to a female aged 10–59 years with a diagnosis of epilepsy, without history of hysterectomy

10

Valproate F

Prescription of sodium valproate to a female aged 10–59 years, without history of hysterectomy OR epilepsy

  1. aeGFR estimated glomerular filtration rate, specified here as having been calculated with the Cockcroft-Gault equation
  2. bNSAID Non-steroidal anti-inflammatory drug, e.g. aspirin, ibuprofen, diclofenac, etc.